COMP <GO>
AHCO vs ABBV // GROSS PROFIT MARGIN
AdaptHealth Corp. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: AHCO 1
— ABBV 10
▲ GROSS PROFIT MARGIN LEADER: ABBV
LAST: $5.93 (-1.66%) • MKT CAP: $808.5M
gross-margins
18.80%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHCO VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHCO | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 18.80% | 70.20% | -51.40 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.20% | 29.00% | -26.80 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 33.3x | -27.20 | AHCO | /valuation <GO> |
| Free Cash Flow Yield | — | 3.47% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 2.80% | 24.60% | -21.80 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -2.20% | 6.90% | -9.10 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | -0.50% | 8.60% | -9.10 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.79 | 5.33 | -4.54 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.2 | 65.1 | -20.87 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $808.5M | $513.86B | -$513.05B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHCO REV | ABBV REV | AHCO GROSS % | ABBV GROSS % | AHCO FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.24B | $61.16B | 18.8% | 70.2% | $219.4M | $17.82B |
| FY 2024 | $3.26B | $56.33B | 20.9% | 70.0% | $235.8M | $17.83B |
| FY 2023 | $3.20B | $54.32B | — | — | $480.7M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHCO // BETA —
ABBV // BETA 1.15